跳至主要内容
临床试验/CTRI/2019/09/021112
CTRI/2019/09/021112Other不适用

India Heart Study – The Ongoing Outcomes (IHS TOO)

Eris Lifescience Ltd1 个研究点 分布在 1 个国家目标入组 8,000 人开始时间: 2019年10月21日最近更新:

试验速览

阶段
不适用
状态
Other
发起方
入组人数
8,000
试验地点
1
主要终点
The primary objective of the study is long term follow up of the natural history of the subjects enrolled for a period of 5 years.

研究概览

简要总结

High blood pressure (BP) is ranked as thethird most important risk factor for increased burden of disease in south Asia(2010). Hypertension (HTN) exerts a substantial public health burden oncardiovascular health status and healthcare systems in India. HTN is directlyresponsible for 57% of all stroke deaths and 24% of all coronary heart disease(CHD) deaths in India. Hypertension is a major cardiovascular risk with anestimated prevalence of 27% of the adult Indian population. However, bothdiagnosis and treatment of high blood pressure highly depends on method ofblood pressure measurement.

The present study proposal has an observationalprospective long-term follow up design. It aims at investigating the differencebetween standardized office and self-blood pressure measurement and relatedconsequences for diagnosis of hypertension in Indian primary care practice. Inthe long-term this study aims at providing more insight into subject’s bloodpressure profile and other subject characteristics in relation to long-termcardiovascular risk.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • Male or female subjects aged 18 years and older without a history of hypertension
  • Office systolic blood pressure between 100 and 180 mmHg and diastolic blood pressure between 60 and 110 mmHg.

排除标准

  • Subjects who are unable or unwilling to take self-measurements of blood pressure at home
  • Subjects who do not sign informed consent
  • Office Blood pressure higher than 180 and 110 mmHg for systolic and diastolic blood pressure, respectively
  • Patients with secondary Hypertension
  • Patients already on Anti-hypertensive medication.

结局指标

主要结局

The primary objective of the study is long term follow up of the natural history of the subjects enrolled for a period of 5 years.

时间窗: 5 years

次要结局

  • To have better insights on how many normotensive or white coat hypertensive patients turned hypertensive over a course of time and document their natural history.(Record any hospitalizations during follow up for HT-related problems – Time period of Diagnosis (Stroke, ACS, Renal failure etc.))

研究者

发起方
Eris Lifescience Ltd
申办方类型
Pharmaceutical industry-Indian

研究点 (1)

Loading locations...

相似试验